Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.

Also called NCT04967573

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 480 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04967573
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04967573. Randomized; triple masking; primary purpose treatment. Start 2021-08-01 (actual); primary completion 2023-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis
Condition
Venous Thrombosis
Intervention (Drug)
Rivaroxaban
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct04967573
Content hash
88dc4eaa4d2d899a248bdd2654a013e31e940d422209ee8833a74de729e0e10f